분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2016-07-27 17:21:15 , Hit : 1094
 Chinese Scientists To Test Gene Modifying Technique ‘CRISPR’ On Humans For The First Time

Science World Report

First Posted: Jul 23, 2016 05:30 AM EDT

It will be the first attempt ever that a group of Chinese scientists will inject genetically modified cells into human beings next month. The genes have been modified using the CRISPR-Cas9 gene-editing technique. The trial will begin from next month at the West China Hospital, Sichuan University.

Lead oncologist Lu You and his team will test gene-edited cells on lung cancer patients on whom treatments including chemotherapy and radiation therapy have already failed. What the team will do is they will extract immune cells known as T cells from the blood of the patients and use CRISPR-Cas9 to modify them. They will try to eliminate a gene from the cells that encodes a protein named PD-1, which normally keeps immune cells in check but is also used by cancer cells as a defensive mechanism.

The researchers are hoping that after they multiply the modified cells in the lab and re-introduce them into the patients' bloodstream, they will center the cancer and eliminate it. However, it is first to be made sure that the technique is safe, reported Digital Trends.

In the first trial, which begins in August, the research team will inject the CRISPR-edited cells in only one of the three patients in the group. After observing the patient if the team is satisfied by the results, they will perform the same treatment on the second patient. Future trials will depend on how effective the technique is compared to other types of treatment.

"This technique is of great promise in bringing benefits to patients, especially the cancer patients whom we treat every day," said Lu You, reported Daily Mail.

You said that the technology will have wide applications if it has good safety and shows certain efficacy. In fact, it has the potential to become an alternative biotechnology treatment to replace or complement the existing single-antibody drugs, he added, according to journal Nature.

This is for the first time that the CRISPR-Cas9 gene editing technique will be applied on human beings. Previously, Chinese scientists have tested the technique on human embryos and in monkeys and dogs.







1087   microRNA가 췌장암 치료제가 될 수 있을까  이성욱 2015/06/30 1051
1086   Drug flushes out hidden AIDS virus  이성욱 2015/03/07 1053
1085   융합연구리뷰 | Convergence Research Review  이성욱 2016/01/08 1057
1084   정밀의학의 끝: 개인화된 종양백신을 개발하는 과학자들  이성욱 2016/04/26 1059
1083   [바이오토픽] 브로드 연구소, 열띤 CRISPR 특허전쟁에서 승리  이성욱 2017/02/16 1060
1082   Gilead hepatitis C drug highly effective in cirrhosis patients  이성욱 2014/11/14 1065
1081   유전자치료제 연구개발 및 규제 동향 2015-식품의약품안전처  이성욱 2016/01/20 1065
1080   [바이오토픽] C형간염을 3주 만에 치료하는 DAA 3제요법  이성욱 2015/11/02 1069
1079   진화와 질병치료 연구를 진전시킬 새로운 유전 메커니즘  이성욱 2015/02/06 1072
1078   미국 과학·공학·의학 아카데미, 「GM 베이비」의 진행방향에 대한 윤곽 발표  이성욱 2017/02/16 1072
1077   일본의 검증팀 STAP 세포 재현 포기, 오보카타 사임  이성욱 2014/12/23 1074
1076   세계 20여 개국 과학자들, 유전자편집 정상회담 개최  이성욱 2015/12/05 1078
1075   CRISPR Structure Data Reveal How Cas Enzymes Choose Target  이성욱 2017/07/25 1086
1074   옥스포드 나노포어, 휴대용 시퀀서 미니온 출시 임박  이성욱 2015/05/08 1090
1073   암 생존율을 높일 수 있는 면역세포  이성욱 2014/12/16 1091
  Chinese Scientists To Test Gene Modifying Technique ‘CRISPR’ On Humans For The First Time  이성욱 2016/07/27 1094
1071   네안데르탈인과 이웃에 살았던 현생인류의 두개골 발견  이성욱 2015/02/03 1095
1070   [미국] 유전자가위 규제 마련 지연과 기업들의 움직임  이성욱 2016/07/21 1103
1069   유전자편집치료에 희망을 준 백혈병치료  이성욱 2015/11/11 1106
1068   부모의 특징을 자식에게 전달하는 방식: 박테리아의 DNA  이성욱 2015/02/19 1108

[1][2][3][4][5][6][7][8][9] 10 ..[64] [다음 10개]
 

Copyright 1999-2021 Zeroboard / skin by ROBIN